Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTR | P02766 | 2/20 | 0.41 |
| ▸ | C1R | P00736 | 1/20 | 0.41 |
| ▸ | ELANE | P08246 | 6/20 | 0.35 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA7 | P43166 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | PARP1 | P09874 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17166803 | 0.86 | CYP2A6 (0.43) | TTRELANECYP1A2CYP2A6ATM | |
| SCHEMBL20739843 | 0.76 | MCL1 (0.41) | TTRC1RCYP1A2CYP2A6 | |
| SCHEMBL12887720 | 0.75 | ALDH1A1 (0.43) | C1RELANEGPR84CYP1A2CYP2A6 | |
| SCHEMBL23288190 | 0.74 | C1R (0.41) | TTRC1RELANEGPR84CYP1A2 | |
| SCHEMBL28597056 | 0.74 | TTR (0.40) | TTRCYP2A6 | |
| SCHEMBL19142155 | 0.74 | CD44 (0.48) | ELANECYP1A2CYP2A6ATMALDH1A1 | |
| SCHEMBL26293019 | 0.72 | MAPT (0.45) | ATMALDH1A1TSHR | |
| SCHEMBL2096683 | 0.72 | ADORA2A (0.36) | TTRC1R | |
| SCHEMBL13445853 | 0.71 | MAOA (0.48) | ALDH1A1 | |
| SCHEMBL30492096 | 0.71 | MAOA (0.48) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020253445-A1 | ORGANIC ELECTROLUMINESCENT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | 陕西莱特光电材料股份有限公司 | 2020-12-24 | — | — | WO | disclosed |
| US-10381596-B2 | Organic light-emitting display apparatus with an encapsulation unit | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-08-13 | — | — | US | disclosed |
| US-20190051860-A1 | ORGANIC LIGHT-EMITTING DISPLAY APPARATUS | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190051860-A1 | ORGANIC LIGHT-EMITTING DISPLAY APPARATUS | ALDH1A1, AOX1, ALDH1A2 | TTR 2374/4885C1R 497/4885ELANE 3627/4885 |
| US-10381596-B2 | Organic light-emitting display apparatus with an encapsulation unit | ALDH1A1, AOX1, AMY1A | TTR 2213/4885C1R 525/4885ELANE 3323/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.